Danaher (NYSE:DHR – Get Free Report) had its price target cut by research analysts at Evercore from $254.00 to $225.00 in a report issued on Monday,MarketScreener reports. The brokerage presently has an “outperform” rating on the conglomerate’s stock. Evercore’s target price points to a potential upside of 17.89% from the stock’s previous close.
Other equities research analysts have also issued reports about the company. TD Cowen restated a “buy” rating on shares of Danaher in a research report on Wednesday, January 7th. Weiss Ratings restated a “hold (c)” rating on shares of Danaher in a report on Friday, March 27th. Argus set a $265.00 target price on Danaher in a research note on Wednesday, January 14th. Wells Fargo & Company lifted their price target on Danaher from $230.00 to $240.00 and gave the company an “equal weight” rating in a report on Monday, December 15th. Finally, The Goldman Sachs Group decreased their price objective on shares of Danaher from $270.00 to $265.00 and set a “buy” rating on the stock in a report on Thursday, January 29th. Nineteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Danaher presently has a consensus rating of “Moderate Buy” and a consensus target price of $252.10.
Get Our Latest Stock Analysis on DHR
Danaher Stock Down 0.1%
Danaher (NYSE:DHR – Get Free Report) last released its quarterly earnings results on Tuesday, January 27th. The conglomerate reported $2.23 EPS for the quarter, beating analysts’ consensus estimates of $2.14 by $0.09. The firm had revenue of $6.84 billion for the quarter, compared to analyst estimates of $6.79 billion. Danaher had a net margin of 14.71% and a return on equity of 10.81%. The company’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same period in the previous year, the business earned $2.14 earnings per share. Equities research analysts predict that Danaher will post 7.63 earnings per share for the current fiscal year.
Insiders Place Their Bets
In other Danaher news, EVP Gregory M. Milosevich sold 1,320 shares of the firm’s stock in a transaction that occurred on Thursday, February 19th. The shares were sold at an average price of $208.01, for a total value of $274,573.20. Following the transaction, the executive vice president directly owned 5,099 shares of the company’s stock, valued at approximately $1,060,642.99. This trade represents a 20.56% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 11.10% of the stock is owned by corporate insiders.
Institutional Trading of Danaher
A number of institutional investors and hedge funds have recently modified their holdings of the stock. Enterprise Financial Services Corp grew its holdings in Danaher by 1.4% during the fourth quarter. Enterprise Financial Services Corp now owns 3,219 shares of the conglomerate’s stock valued at $737,000 after purchasing an additional 46 shares during the period. Kennebec Savings Bank raised its holdings in Danaher by 1.4% in the fourth quarter. Kennebec Savings Bank now owns 3,348 shares of the conglomerate’s stock worth $766,000 after purchasing an additional 46 shares during the period. Revolve Wealth Partners LLC boosted its position in shares of Danaher by 2.6% during the fourth quarter. Revolve Wealth Partners LLC now owns 1,870 shares of the conglomerate’s stock worth $428,000 after purchasing an additional 47 shares in the last quarter. High Note Wealth LLC boosted its position in shares of Danaher by 19.2% during the fourth quarter. High Note Wealth LLC now owns 292 shares of the conglomerate’s stock worth $67,000 after purchasing an additional 47 shares in the last quarter. Finally, First Command Advisory Services Inc. grew its holdings in shares of Danaher by 4.4% in the 4th quarter. First Command Advisory Services Inc. now owns 1,104 shares of the conglomerate’s stock valued at $253,000 after buying an additional 47 shares during the period. 79.05% of the stock is owned by institutional investors.
About Danaher
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Recommended Stories
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
